Astrazeneca Pharma India Demonstrates Strong Market Position with Significant Stock Performance

Astrazeneca Pharma India has shown significant activity today, with the stock rising by 3.36% as of July 15, 2025. This performance has allowed it to outperform the sector by 2.84%, reflecting its strong market position within the Pharmaceuticals and Biotechnology industry. The stock reached an intraday high of Rs 9649.6, marking a notable increase of 5.21%.
In terms of moving averages, Astrazeneca Pharma India is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a positive trend in its price movement. Over the past year, the stock has delivered an impressive return of 43.87%, significantly outpacing the Sensex, which has only gained 2.16% during the same period.

Year-to-date, Astrazeneca Pharma India has achieved a return of 29.29%, further solidifying its strong performance metrics. Additionally, the stock has demonstrated remarkable growth over the last three years, with a staggering increase of 218.45%, compared to the Sensex's 53.29%. This consistent upward trajectory highlights Astrazeneca Pharma India's robust position in the market.